Share
Journal Information
Most Often Read
65482
Skin manifestations of liver diseasesA. Koulaouzidis;, S. Bhat;, J. Moschos
Ann Hepatol. 2007;6:181-4
65482
Open access
19456
COVID-19 and the liver: What do we know after six months of the pandemic?Nora A. Fierro
Ann Hepatol. 2020;19:590-1
19456
Open access
Open Article
13051
Shark liver oil: hidden dangersSerta Kilincalp, Murat Deveci, Omer Basar, Fuat Ekiz, Sahin Coban, Osman Yuksel
Ann Hepatol. 2012;11:728-30
13051
Open access
7806
Diagnosis of liver nodules within and outside screening programsMassimo Colombo
Ann Hepatol. 2015;14:304-9
7806
Open access
7244
Current concepts in acute liver failureMaximiliano Rovegno, Magdalena Vera, Alex Ruiz, Carlos Benítez
Ann Hepatol. 2019;18:543-52
7244
Open access
6127
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)Juan P. Arab, Juan P. Roblero, Jose Altamirano, Fernando Bessone, Roberta Chaves Araujo, Fatima Higuera-De la Tijera, Juan Carlos Restrepo, Aldo Torre, Alvaro Urzua, Douglas A. Simonetto, Juan G. Abraldes, Nahum Méndez-Sánchez, Fernando Contreras, Michael R. Lucey, Vijay H. Shah, Helena Cortez-Pinto, Ramon Bataller
Ann Hepatol. 2019;18:518-35
6127
Open access
6099
Report of the Baveno VI Consensus WorkshopAndres Cardenas, Angela Mendez-Bocanegra
Ann Hepatol. 2016;15:289-90
6099
Open access
5536
Treatment of hyperferritinemiaMelanie D. Beaton, Paul C. Adams
Ann Hepatol. 2012;11:294-300
5536
Open access
5489
Transmission routes of hepatitis C virus infectionEduardo Zumaeta Villena
Ann Hepatol. 2006;5 Supl 1:S12-4
5489
Open access
5390
Multiple Biliary Hamartomas, The ‘‘Von Meyenburg Complexes’’Joel O. Jáquez-Quintana, Erick A. Reyes-Cabello, Francisco J. Bosques-Padilla
Ann Hepatol. 2017;16:812-3
5390
Open access
5280
Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathyClaudia Isabel Blanco Vela, Jorge Luis Poo Ramírez
Ann Hepatol. 2011;10 Supl 2:S55-9
5280
Open access
4820
Acute liver injury, acute liver failure and acute on chronic liver failure: A clinical spectrum of poisoning due to Gyromitra esculentaMagdalena Arłukowicz-Grabowska, Maciej Wójcicki, Joanna Raszeja-Wyszomirska, Monika Szydłowska-Jakimiuk, Bernard Piotuch, Piotr Milkiewicz
Ann Hepatol. 2019;18:514-6
4820
Open access
4726
Management Strategies for Liver FibrosisAlejandra Altamirano-Barrera, Beatriz Barranco-Fragoso, Nahum Méndez-Sánchez
Ann Hepatol. 2017;16:48-56
4726
Open access
4631
Anti-cancer effects of blue-green alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compoundsRenata Koníčková, Kateřina Vaňková, Jana Vaníková, Katerina Vánová, Lucie Muchová, Iva Subhanová, Marie Zadinová, Jaroslav Zelenka, Ales Dvořák, Michal Kolář, Hynek Strnad, Silvie Rimpelová, Tomas Ruml, Ronald J. Wong, Libor Vítek
Ann Hepatol. 2014;13:273-83
4631
Open access
4523
Effects of systemic chemotherapy on the liverGiuliano Ramadori, Silke Cameron
Ann Hepatol. 2010;9:133-43
4523
Open access
4476
New Insights About Albumin and Liver DiseaseJoana R. Carvalho, Mariana Verdelho Machado
Ann Hepatol. 2018;17:547-60
4476
Open access
4250
The liver in times of COVID-19: What hepatologists should knowEzequiel Ridruejo, Alejandro Soza
Ann Hepatol. 2020;19:353-8
4250
Open access
Open Article
4237
AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosisAurora Loaeza-del-Castillo, Francisco Paz-Pineda, Edgar Oviedo-Cárdenas, Francisco Sánchez-Ávila, Florencia Vargas-Vorácková
Ann Hepatol. 2008;7:350-7
4237
Open access
4220
Patterns of viral load in chronic hepatitis B patients in Brazil and their association with ALT levels and HBeAg statusMarcelo Eidi Nita, Nelson Gaburo, Hugo Cheinquer, Gilbert L’ltalien, Evaldo Stanislau Affonso de Araujo, Patricia Mantilla, Nancy Cure-Bolt, Paulo A. Lotufo
Ann Hepatol. 2009;8:339-45
4220
Open access
Special content about COVID-19
Publish in
Annals of Hepatology
Affiliated societies
